Skip to main content

Advertisement

SpringerLink
Log in

Renal Denervation for Patients With Atrial Fibrillation

  • Invasive Electrophysiology and Pacing (E. Kevin Heist, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

During the last decade, several case series and small reports have indicated that pulmonary vein isolation (PVI) in combination with renal denervation (RDN) may increase the rate of atrial fibrillation (AF) freedom in patients with hypertension. We aimed to provide a contemporary systematic overview on the techniques, and the efficacy/safety of RDN on AF recurrence, and the current landscape of ongoing investigation.

Recent Findings

The recent Evaluate Renal Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation (ERADICATE-AF) trial has demonstrated convincingly that among patients with paroxysmal AF and poorly controlled (but not “resistant”) hypertension, RDN added to catheter ablation, compared with catheter ablation alone, significantly increased the likelihood of freedom from AF at 12 months.

Summary

RDN has proven to be a unique, effective and safe interventional therapy for the management of AF. Future investigation will likely focus on confirming current findings; expanding the population of eligible patients (eg., non-hypertensives, well controlled hypertensives); determining long-term maintenance of effect and therapeutics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med. 1976;294:1165–70.

    Article  CAS  Google Scholar 

  2. Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, Bloise R, Ferrari GMD, Klersy C, Moss AJ, Zareba W, Robinson JL, Hall WJ, Brink PA, Toivonen L, Epstein AE, Li C and Hu D. Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome. 2004;109:1826-1833.

  3. Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 1976;37:1034–40.

    Article  CAS  Google Scholar 

  4. Kadowaki MH, Levett JM. Sympathectomy in the treatment of angina and arrhythmias. The Annals of Thoracic Surgery. 1986;41:572–8.

    Article  CAS  Google Scholar 

  5. Bos JM, Bos KM, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders. Circ Arrhythm Electrophysiol. 2013;6:705–11.

    Article  Google Scholar 

  6. Kallistratos MS, Poulimenos LE, Manolis AJ. Atrial fibrillation and arterial hypertension. Pharmacological research. 2018;128:322–6.

    Article  CAS  Google Scholar 

  7. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–78.

    Article  Google Scholar 

  8. Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet. 2015;385:1957–65.

    Article  Google Scholar 

  9. Kandzari DE, Böhm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018;391:2346–55.

    Article  Google Scholar 

  10. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393–401.

    Article  CAS  Google Scholar 

  11. Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018;391:2335–45.

    Article  Google Scholar 

  12. Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390:2160–70.

    Article  Google Scholar 

  13. Ukena C, Mahfoud F, Spies A, Kindermann I, Linz D, Cremers B, et al. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. International Journal of Cardiology. 2013;167:2846–51.

    Article  Google Scholar 

  14. Hou Y, Hu J, Po SS, Wang H, Zhang L, Zhang F, et al. Catheter-based renal sympathetic denervation significantly inhibits atrial fibrillation induced by electrical stimulation of the left stellate ganglion and rapid atrial pacing. PLoS One. 2013;8:e78218.

    Article  CAS  Google Scholar 

  15. •• Steinberg JS, Shabanov V, Ponomarev D, Losik D, Ivanickiy E, Kropotkin E, et al. Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial. JAMA. 2020;323:248–55 The largest and the most recent multicenter single-blind randomized clinical trial that evaluated the additional effect of renal denervation on top of ablation for patients with atrial fibrillation. The study demonstrated a signmificant reisk reduction for AF among those who underwent renal denervation.

    Article  Google Scholar 

  16. Peet MM. Results of Bilateral Supradiaphragmatic Splanchnicectomy for Arterial Hypertension. 1947;236:270-277.

  17. Bunte MC, Infante de Oliveira E, Shishehbor MH. Endovascular tTreatment of Resistant resistant and Uncontrolled uncontrolled Hypertensionhypertension: Therapies therapies on the Horizonhorizon. JACC: Cardiovascular Interventions. 2013;6:1–9.

    PubMed  Google Scholar 

  18. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. The Lancet. 2009;373:1275–81.

    Article  Google Scholar 

  19. Bertog SC, Sobotka PA, Sievert H. Renal Denervation for Hypertension. JACC: Cardiovascular Interventions. 2012;5:249–58.

    PubMed  Google Scholar 

  20. Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clinical Research in Cardiology. 2011;100:1095–101.

    Article  Google Scholar 

  21. Akinseye OA, Ralston WF, Johnson KC, Ketron LL, Womack CR, Ibebuogu UN. Renal Sympathetic Denervation: A Comprehensive Review. Current Problems in Cardiology. 2020;100598.

  22. Zhang H, Prince MR. Renal MR angiography. Magnetic resonance imaging clinics of North America. 2004;12:487–503 vi.

    Article  Google Scholar 

  23. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension. 2013;61:457–64.

    Article  CAS  Google Scholar 

  24. Chen LY, Shen WK. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm. 2007;4:S1–6.

    Article  Google Scholar 

  25. Zhao Q, Yu S, Zou M, Dai Z, Wang X, Xiao J, et al. Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol. 2012;35:119–25.

    Article  Google Scholar 

  26. Zhao Q, Yu S, Huang H, Tang Y, Xiao J, Dai Z, et al. Effects of renal sympathetic denervation on the development of atrial fibrillation substrates in dogs with pacing-induced heart failure. Int J Cardiol. 2013;168:1672–3.

    Article  Google Scholar 

  27. Huang B, Yu L, Scherlag BJ, Wang S, He B, Yang K, et al. Left renal nerves stimulation facilitates ischemia-induced ventricular arrhythmia by increasing nerve activity of left stellate ganglion. J Cardiovasc Electrophysiol. 2014;25:1249–56.

    Article  Google Scholar 

  28. Parkash R, Wells GA, Sapp JL, Healey JS, Tardif JC, Greiss I, et al. Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]). Circulation. 2017;135:1788–98.

    Article  CAS  Google Scholar 

  29. Giannopoulos G, Kossyvakis C, Efremidis M, Katsivas A, Panagopoulou V, Doudoumis K, et al. Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: a randomized, controlled study. Circulation. 2014;130:1346–52.

    Article  CAS  Google Scholar 

  30. • Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163–70 The pilot study that demonstrated safety and efficacy for renal denervation in reducing atrial fibrillation recurrence among patients with atrial fibrillation.

    Article  Google Scholar 

  31. Pokushalov E, Romanov A, Katritsis DG, Artyomenko S, Bayramova S, Losik D, et al. Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience. Heart Rhythm. 2014;11:1131–8.

    Article  Google Scholar 

  32. Kiuchi MG, Chen S, Gr ES, Rodrigues Paz LM, Kiuchi T, de Paula Filho AG, et al. The addition of renal sympathetic denervation to pulmonary vein isolation reduces recurrence of paroxysmal atrial fibrillation in chronic kidney disease patients. J Interv Card Electrophysiol. 2017;48:215–22.

    Article  Google Scholar 

  33. Atti V, Turagam MK, Garg J, Lakkireddy D. Renal sympathetic denervation improves clinical outcomes in patients undergoing catheter ablation for atrial fibrillation and history of hypertension: A meta-analysis. J Cardiovasc Electrophysiol. 2019;30:702–8.

    Article  Google Scholar 

  34. Chen S, Kiuchi MG, Yin Y, Liu S, Schratter A, Acou WJ, et al. Synergy of pulmonary vein isolation and catheter renal denervation in atrial fibrillation complicated with uncontrolled hypertension: mMapping the renal sympathetic nerve and pulmonary vein (the pulmonary vein isolation plus renal denervation strategy)? J Cardiovasc Electrophysiol. 2019;30:658–67.

    Article  Google Scholar 

  35. Kiuchi MG, Chen S, Gr ES, Paz LM, Kiuchi T, de Paula Filho AG, et al. Pulmonary vein isolation alone and combined with renal sympathetic denervation in chronic kidney disease patients with refractory atrial fibrillation. Kidney research and clinical practice. 2016;35:237–44.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Cardiovascular Research Center, University of Rochester School of Medicine and Dentistry, 85 Woodland Road, Short Hills, NJ, 07078, USA

    Arwa Younis & Jonathan S. Steinberg

Authors
  1. Arwa Younis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan S. Steinberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan S. Steinberg.

Ethics declarations

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of Interest

Arwa Younis declares no conflict of interest.

Jonathan S. Steinberg reports: Consultant for Medtronic, National Cardiac, Allergan, Atricure, Corfigo, Braveheart, Hillrom; equity in National Cardiac, AliveCor, Braveheart; and research support from the National Institutes of Health and Medtronic.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Invasive Electrophysiology and Pacing

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Younis, A., Steinberg, J.S. Renal Denervation for Patients With Atrial Fibrillation. Curr Cardiol Rep 23, 126 (2021). https://doi.org/10.1007/s11886-021-01558-4

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11886-021-01558-4

Keywords

Search

Navigation